3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Hyperglycemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Gao, T; Hu, C; Jin, H; Xie, X; Yang, L; Yang, M; Yi, J; Yu, X; Zhang, S; Zhang, X | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Hyperglycemia
| Article | Year |
|---|---|
Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population.
Topics: Asian People; China; CRISPR-Associated Protein 9; CRISPR-Cas Systems; Furans; Humans; Hyperglycemia; Insulin-Secreting Cells; Mutation; Propionates | 2017 |